Article

Promising Hepatitis C Drugs Highlight AJPB Week in Review

Author(s):

AJPB staff

Top articles of the week from The American Journal of Pharmacy Benefits.

Related Videos
Patient receiving cancer treatment infusion -- Image credit: UlrikaArt | stock.adobe.com
Small cell lung cancer -- Image credit: LASZLO | stock.adobe.com
Related Content
NCCN 2025: Advancing Breast Cancer Risk Assessment and Prevention Strategies
April 1st 2025

NCCN 2025: Advancing Breast Cancer Risk Assessment and Prevention Strategies

Luke Halpern, Assistant Editor
Pharmacy focus podcast
March 28th 2025

From Screening to Survival: The Pharmacist’s Role in Colorectal Cancer

Alexandra Gerlach, Associate Editor
Patient with an IV in their arm -- Image credit: sinhyu | stock.adobe.com
March 31st 2025

FDA Grants BA1302 Orphan Drug Designation for Squamous NSCLC and Pancreatic Cancer

Gillian McGovern, Associate Editor
The AQUILA Debate: Daratumumab for Treatment of Smoldering Multiple Myeloma
January 31st 2025

The AQUILA Debate: Daratumumab for Treatment of Smoldering Multiple Myeloma

Alexandra Gerlach, Associate Editor
ACC 2025: Lower-Dose Apixaban Is Effective, Safer Than Full Dose for Preventing VTE Recurrence in Patients With Cancer
March 29th 2025

ACC 2025: Lower-Dose Apixaban Is Effective, Safer Than Full Dose for Preventing VTE Recurrence in Patients With Cancer

Aislinn Antrim, Managing Editor
a close-up of a lung with cancer cells and an overlay of a magnified section of a blood sample Generative AI
March 29th 2025

NCCN 2025: Immune Checkpoint Inhibitors Expand Treatment Options for Early-Stage NSCLC

Luke Halpern, Assistant Editor